HYP_preeclampsia_interventions_economic_cctr_17102008

#SearchesResults
1costs.tw.5410
2cost effective$.tw.4135
3economic.tw.2275
4or/1–38908
5(metabolic adj cost).tw.38
6((energy or oxygen) adj cost).tw.178
74 not (5 or 6)8898
8HELLP SYNDROME/ or PRE-ECLAMPSIA/405
9pre eclamp$.tw.261
10pre?eclamp$.tw.401
11HELLP.tw.42
12tox?emi$.tw.61
13or/8–12791
14METHYLDOPA/302
15exp PRAZOSIN/627
16HYDRALAZINE/251
17LABETALOL/325
18ATENOLOL/1535
19OXPRENOLOL/199
20NIFEDIPINE/1847
21AMLODIPINE/656
22NICARDIPINE/295
23BENDROFLUMETHIAZIDE/191
24exp THIAZIDES/0
25ASPIRIN/3381
26DIPYRIDAMOLE/502
27exp ANGIOTENSIN-CONVERTING ENZYME INHIBITORS/4619
28(ace adj3 inhibitor$).tw.2134
29exp ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS/0
30(angiotensin adj3 receptor$ adj antagonist$).tw.348
31AIIRAS.tw.2
32or/27–315597
33BETAMETHASONE/642
34DEXAMETHASONE/1723
35HYDROCORTISONE/3605
36PREDNISONE/2328
37or/14–3621545
38and/7,13,372

From: Appendix E, Search strategies

Cover of Hypertension in Pregnancy
Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy.
NICE Clinical Guidelines, No. 107.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2010 Aug.
Copyright © 2011, Royal College of Obstetricians and Gynaecologists.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.